“Mae’r pandemig yn rhoi rhagor o bwysau ar y cyflenwad hwnnw oherwydd yr angen cynyddol am blasma gwaed i ddatblygu meddyginiaethau Covid-19 newydd ynghyd â’r gostyngiad mewn rhoddion plasma gwaed.
“The pandemic is placing further pressures on this supply due to the increased need for blood plasma in the development of new Covid-19 medicines coupled with the falling numbers of blood plasma donations.